The Global Fund to Fight Aids, Tuberculosis and Malaria will start to cut its grant support to South Africa in just two years, with its final grant ending in eight years. Some experts are worried the government isn’t doing enough to plan for it
None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab
A comprehensive, multi-sector approach would help medical care in emerging countries catch up with those in more established nations
The US government has appointed the first African head of its Aids fund, Pepfar. John Nkengasong, a Cameroonian virologist
No image available
/ 6 November 2008
An aid agency has decided against giving new healthcare funds to Zimbabwe to fight HIV/Aids until the country’s central bank returns -million.
The Global Fund to Fight Aids, Tuberculosis and Malaria has awarded Russia a two-year, $34,2- million grant for treatment.